Novel Top‐Down Technologies: Effective Production of Ultra‐Fine Drug Nanocrystals
Authors:
- C.M. KeckC.M. Keck
- S. KobierskiSKS. Kobierski
- R. MauludinR. Mauludin
- R.H. MüllerRMR.H. Müller
- 21 January 2013
- book chapter
- Published by Wiley
- p. 247-263
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- State of the art of nanocrystals – Special features, production, nanotoxicology aspects and intracellular deliveryEuropean Journal of Pharmaceutics and Biopharmaceutics, 2011
- Production and characterization of Hesperetin nanosuspensions for dermal deliveryInternational Journal of Pharmaceutics, 2009
- When poor solubility becomes an issue: From early stage to proof of conceptEuropean Journal of Pharmaceutical Sciences, 2007
- Drug Nanocrystals/Nanosuspensions for the Delivery of Poorly Soluble Drugs2006
- Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technologyEuropean Journal of Pharmaceutics and Biopharmaceutics, 2004
- Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in ratsInternational Journal of Pharmaceutics, 1995
- The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugsInternational Journal of Pharmaceutics, 1995
- A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo BioavailabilityPharmaceutical Research, 1995
- Targeting of Teniposide to the Mononuclear Phagocytic System (MPS) by Incorporation in Liposomes and Submicron Lipid Particles; An Autoradiographic Study in MiceLeukemia & Lymphoma, 1995
- The relationship between particle size and solubilityInternational Journal of Pharmaceutics, 1992